鈴木 真 | 台糖ファイザー株式会社新薬開発センター
スポンサーリンク
概要
論文 | ランダム
- OJ-325 Regulation of cardiovascular remodeling by inhibitor of PDGF receptor tyrosine kinase(Cardiovascular Pharmacology, Basic/Clinical 2 (H) : OJ39)(Oral Presentation (Japanese))
- OE-319 KLF5 inhibitor, Am80, reduces adipose tissue growth and fatty liver disease in leptin-deficient (ob/ob) mice.(Diabetes/Obesity 2 (H) : OE40)(Oral Presentation (English))
- OE-291 Novel Angiogenic Properties of Adrenomedullin in Ischemia, Tumor Growth and Development(Genetics/Genetically Engineered Models 2 (H) : OE36)(Oral Presentation (English))
- OE-290 Accelerated Cardiac Hypertrophy under Stress in Adrenomedullin Knockout Mice through PKA and PKC Pathway(Genetics/Genetically Engineered Models 2 (H) : OE36)(Oral Presentation (English))
- OE-114 Kruppel-like Zinc-finger Transcription Factor KLF5/BTEB2 is an Essential Regulator of Cardiovascular Remodeling(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English))